EM2009B "The New Poison: Clinical and Experimental Evidence of Phosphotoxicity" (IM GR-091120)
Purpose and Overview
- Introduce and explain the concept of phosphotoxicity for the general population
- Review the preclinical and clinical data supporting its existence.
- Know the different kinds of phosphate in the diet with different bioavailability, and the unnecessary excess of added phosphate in our diet
- Propose what measures can be taken in the present and in the future by the biomedical community.
UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.
At the conclusion of this activity, the participant should be able to:
- Understand the concept and know the preclinical and clinical data supporting phosphotoxicity.
- Know that our current dietary intake is way above what is needed for health and even if phosphate is not toxic, it is not necessary to ingest our current level of consumption.
- An important step for the scientific and medical community is to educate the public and provide basic, translational, and clinical data for the FDA to instigate regulation on the food industry in disclosing and limiting added inorganic phosphate.
Orson Moe, M.D.
Professor, Departments of Internal Medicine & Physiology Director,
Pak Center for Mineral Metabolism & Clinical Research
Division Chief, Nephrology
- 1.00 AMA